IP Library Granted Patent US 8,014,854
Granted Patent B2
US 8,014,854 · App. 12/173,639 · Granted Sep 6, 2011

Method and device for treating abnormal tissue growth with electrical therapy

Assignee: Ionix Medical Inc.
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,014,854
App. No.
12/173,639
Granted
Sep 6, 2011
Kind
B2
Abstract

This invention relates generally to the electrical treatment of malignant tumors and neoplasms by applying a voltage to affected tissue. Devices and various adaptations therein are described for use in electrical therapy. Additionally, various chemotherapeutic agent and radiation therapies are described which may be advantageously used in conjunction with electrical therapy to ameliorate cancer.

Claims (8)

1. A method for the treatment of abnormal tissue growth madeup of abnormal cells, the method comprising:

providing circuitry coupled to a power source;

providing at least one electrode operably coupled to said circuitry; and delivering through said circuitry direct current electrical therapy as a series of

voltage pulses between 20 and 900 volts for ablating at least one abnormal cell and simultaneously causing electroporation of at least one abnormal cell;

wherein said electrical therapy is delivered at a duty cycle in the range of 50 to 70 percent.

2. The method of claim 1 wherein said direct current electrical therapy is applied at voltages and time periods sufficient for changing the pH by at least 2.0 inside said abnormal tissue growth.

3. The method of claim 1 wherein said direct current electrical therapy is applied for a period of time not less than 1 minute.

4. The method of claim 1 wherein said direct current electrical therapy is delivered in pulses numbering between 1 and 10,000.

Assignments (2)
CHANGE OF NAME Recorded Jul 26, 2011
From: ONCOSTIM, INC.
To: IONIX MEDICAL INC.
Reel/Frame 026653/0810 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 8, 2008
From: SCHROEPPEL, EDWARD A.; KROLL, MARK W.; KROLL, KAI
To: ONCOSTIM, INC.
Reel/Frame 021649/0815 →
Continuity (4)
Continuation 10434400 · May 7, 2003
Continuation In Part 09974474 · Dec 14, 2001
Continuation In Part 09524405 · Mar 13, 2000
Related Publication 20090024075A1 · Jan 22, 2009